Skip to main content
. Author manuscript; available in PMC: 2017 Aug 9.
Published in final edited form as: Cancer Res. 2016 Jun 3;76(15):4516–4524. doi: 10.1158/0008-5472.CAN-16-0416

Figure 1.

Figure 1

A, competitive inhibition curves of [125I]KX1 with various PARPis in multiple cell lines. B, the structural similarities of KX1 and analogue PARPi rucaparib are illustrated.